Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
  1. Home
  2. Stock
  3. CGNX
CGNX logo

CGNX Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Cognex Corp (CGNX) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Buy
Latest Price
50.790
1 Day change
0.42%
52 Week Range
59.880
Analysis Updated At
2026/03/06
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

Cognex Corp (CGNX) is a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. Despite recent price declines, the company's strong financial performance, positive analyst sentiment, and hedge fund buying activity indicate long-term growth potential. The lack of recent negative news and the company's focus on margin expansion further support this decision.

Technical Analysis

The stock's MACD is negative and expanding downward (-0.82), indicating bearish momentum. RSI is at 29.599, suggesting the stock is nearing oversold territory. Moving averages are bullish (SMA_5 > SMA_20 > SMA_200), and the stock is trading near its key support level of 51.66, which could act as a floor for price stabilization.

Options Data

Bullish
Open Interest Put-Call Ratio
Bearish
Option Volume Put-Call Ratio

The low open interest put-call ratio indicates bullish sentiment, while the high option volume put-call ratio suggests short-term bearish activity. Implied volatility is moderate (44.66), with an IV percentile of 58.96, indicating options are relatively expensive but not extreme.

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
3
Buy
8

Positive Catalysts

  • Hedge funds are significantly increasing their buying activity (up 2450.31% over the last quarter).

  • Analysts have raised price targets significantly, with multiple buy ratings and targets ranging up to $

  • Strong Q4 financials with revenue up 9.86% YoY, net income up 15.23% YoY, and EPS up 18.75% YoY.

  • Positive sentiment around the company's margin expansion and cost reduction initiatives.

Neutral/Negative Catalysts

  • Insiders are selling heavily, with a 4627.11% increase in selling activity over the last month.

  • Gross margin dropped by 4.34% YoY in Q4

  • Recent price decline of -3.61% in the regular market and -1.64% pre-market indicates short-term bearish pressure.

Financial Performance

In Q4 2025, Cognex reported strong financials with revenue increasing by 9.86% YoY to $252.3M, net income rising by 15.23% YoY to $32.66M, and EPS growing by 18.75% YoY to $0.19. However, gross margin declined by 4.34% YoY to 65.75%. The company is focusing on margin expansion and cost reduction, which is expected to drive long-term growth.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Analysts are generally positive on Cognex, with multiple firms raising price targets significantly (up to $75) and issuing buy ratings. Analysts highlight strong Q4 performance, margin expansion, and a positive outlook for 2026. However, some firms maintain neutral ratings due to valuation concerns.

Wall Street analysts forecast CGNX stock price to fall
6 Analyst Rating
Wall Street analysts forecast CGNX stock price to fall
3 Buy
2 Hold
1 Sell
Moderate Buy
Current: 50.580
sliders
Low
35
Averages
45.33
High
54
Current: 50.580
sliders
Low
35
Averages
45.33
High
54
JPMorgan
Underweight -> Neutral
upgrade
$55
AI Analysis
2026-03-09
New
Reason
JPMorgan
Price Target
$55
AI Analysis
2026-03-09
New
upgrade
Underweight -> Neutral
Reason
JPMorgan upgraded Cognex to Neutral from Underweight with an unchanged price target of $55. The firm says the company's "rapid" margin improvement, cost initiatives, and expanding customer base warrant an upgrade to Neutral. Cognex's execution and a strengthening macro backdrop justify a premium valuation for the shares, positioning the company for further upside as sector rotation favors innovation and operational leverage, the analyst tells investors in a research note.
Baird
Richard Eastman
Neutral
maintain
$45 -> $55
2026-02-17
Reason
Baird
Richard Eastman
Price Target
$45 -> $55
2026-02-17
maintain
Neutral
Reason
Baird analyst Richard Eastman raised the firm's price target on Cognex to $55 from $45 and keeps a Neutral rating on the shares. The firm updated its model following Q4 results and where the 2026 focus now turns to margins.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for CGNX
Unlock Now

People Also Watch